SESEN BIO INC's ticker is SESN and the CUSIP is 817763105. A total of 75 filers reported holding SESEN BIO INC in Q2 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $58 | -99.9% | 94,821 | -29.7% | 0.00% | – |
| Q3 2022 | $57,000 | -47.7% | 134,921 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $109,000 | +91.2% | 134,921 | +41.6% | 0.00% | – |
| Q1 2022 | $57,000 | -31.3% | 95,296 | -6.7% | 0.00% | – |
| Q4 2021 | $83,000 | +1.2% | 102,116 | -1.0% | 0.00% | – |
| Q3 2021 | $82,000 | -80.0% | 103,116 | +16.6% | 0.00% | -100.0% |
| Q2 2021 | $409,000 | +339.8% | 88,451 | +146.8% | 0.00% | +100.0% |
| Q1 2021 | $93,000 | +173.5% | 35,840 | +43.9% | 0.00% | – |
| Q4 2020 | $34,000 | -2.9% | 24,900 | 0.0% | 0.00% | – |
| Q3 2020 | $35,000 | +94.4% | 24,900 | 0.0% | 0.00% | – |
| Q2 2020 | $18,000 | +28.6% | 24,900 | 0.0% | 0.00% | – |
| Q1 2020 | $14,000 | -46.2% | 24,900 | -0.4% | 0.00% | – |
| Q4 2019 | $26,000 | -10.3% | 25,000 | 0.0% | 0.00% | – |
| Q3 2019 | $29,000 | -6.5% | 25,000 | +19.6% | 0.00% | – |
| Q2 2019 | $31,000 | – | 20,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,711,672 | $2,311,000 | 0.25% |
| Eversept Partners, LP | 1,559,824 | $2,105,762 | 0.25% |
| Virtu Financial LLC | 270,004 | $365,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 147,452 | $199,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 838,500 | $1,132,000 | 0.02% |
| MIRABELLA FINANCIAL SERVICES LLP | 88,350 | $119,000 | 0.02% |
| Stratos Wealth Partners, LTD. | 263,300 | $355,000 | 0.01% |
| AJ WEALTH STRATEGIES, LLC | 79,365 | $107,000 | 0.01% |
| Schonfeld Strategic Advisors LLC | 349,176 | $471,000 | 0.01% |
| Qube Research & Technologies Ltd | 330,303 | $446,000 | 0.01% |